The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
| RSLBX | |
| Total Expense Ratio | 1.75 |
| Annual Report Gross Expense Ratio | 1.75 |
| Fund Existence | 24 years |
| Gain YTD | 12.235 |
| Front Load | N/A |
| Min. Initial Investment | 250 |
| Min. Initial Investment IRA | N/A |
| Net Assets | 83.3B |
| Annual Yield % from dividends | 0.05 |
| Returns for 1 year | 6.01 |
| Returns for 3 years | 27.58 |
| Returns for 5 years | -1.78 |
| Returns for 10 years | 46.13 |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| YOLO | 2.97 | 0.08 | +2.75% |
| AdvisorShares Pure Cannabis ETF | |||
| MGK | 413.17 | -1.14 | -0.28% |
| Vanguard Mega Cap Growth ETF | |||
| DEUS | 58.21 | -0.44 | -0.75% |
| Xtrackers Russell US Multifactor ETF | |||
| BAI | 34.29 | -0.48 | -1.38% |
| iShares A.I. Innovation and Tech Active ETF | |||
| THQ | 18.86 | -0.27 | -1.41% |
| abrdn Healthcare Opportunities Fund | |||